Pricing Log in Create free account

Oramed Pharmaceuticals Inc. (ORMP) vs PepGen, Inc. (PEPG)

Oramed Pharmaceuticals Inc. and PepGen, Inc. are both Biotechnology companies. Oramed Pharmaceuticals Inc. and PepGen, Inc. are of similar size ($171.1M and $160.6M). PepGen, Inc. has negative trailing earnings, so its P/E is not meaningful; Oramed Pharmaceuticals Inc. trades at 0.9×. Across the 10 metrics below, Oramed Pharmaceuticals Inc. leads on 8 and PepGen, Inc. on 2.

Valuation

Metric ORMP PEPG Biotechnology median
P/E 0.91 n/m 10.60
P/S 39.40 n/m 9.40
P/B 0.50 1.43 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 26.81 n/m 9.02
Earnings yield 109.59% (53.04%) (32.88%)
Free cash flow yield (3.29%) (40.66%) (23.13%)

Profitability

Metric ORMP PEPG Biotechnology median
Gross margin 32.31% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 73.90% (75.45%) (51.96%)
Return on assets 65.52% (59.06%) (46.06%)
Return on invested capital (3.40%) (2,076.25%) 0.00%

Growth

Metric ORMP PEPG Biotechnology median
Revenue growth (TTM) 48.76% — 6.76%
EPS growth (last fiscal year) 412.50% 25.61% 29.88%
Revenue growth, 5-year CAGR (5.85%) — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ORMP PEPG Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.98 13.36 4.97
Net debt to EBITDA 8.41 1.64 1.01

Dividend

Metric ORMP PEPG Biotechnology median
Dividend yield 6.48% — 0.41%
Payout ratio 0.06 — —

Size

Metric ORMP PEPG Biotechnology median
Market cap 160.57m 171.07m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack